QUBIS

VascVersa is a med-tech company focused on vascular regeneration through innovative regenerative medicine. It has developed a unique cell therapy that stimulates the formation of new blood vessels, enhancing blood supply and promoting long-term healing. This technology enables healthcare professionals to effectively treat patients with ischaemic diseases, addressing critical needs in vascular health. By prioritizing advancements in cell therapies, VascVersa aims to improve patient outcomes and support recovery in those affected by vascular-related conditions.

Sonrai Analytics develops an advanced analytics software platform aimed at enhancing data utilization for businesses in various sectors. Its platform leverages artificial intelligence and machine learning to enable predictive analytics, helping organizations discover new treatments and streamline research development. By addressing the challenges of precision analytics and reproducible data findings, Sonrai's solutions harness the vast amounts of data generated across successful business models. This approach allows companies to move away from outdated methods, facilitating the resolution of complex problems and the identification of competitive advantages in their respective markets.

Aramune Technologies is developing natural, plant derived feed materials which can be mixed with standard animal feeds to replace antimicrobial agents and promote growth.

ŌGI Bio is a newly formed start-up company from The University of Edinburgh with the mission to revolutionize the way that microbes are grown and managed.

Causeway Sensors Ltd. specializes in developing and manufacturing nanotechnology-based point-of-care diagnostic solutions for rapid disease detection. Established in 2013 and headquartered in Belfast, United Kingdom, the company offers a compact biosensor known as The Affinity, which features a chip embedded with a billion gold nanorods. This innovative design allows for sensitive detection of biological events at the chip’s surface. The Affinity biosensor, along with its Access Chip, is intended for biochemistry researchers and provides real-time analysis at an accessible price. Additionally, Causeway Sensors' technology aids pharmaceutical companies by enabling quick data capture during candidate screening for new biological drugs, ultimately helping to reduce development times and costs while improving the quality of drugs.

AntennaWare specializes in developing advanced antenna technology aimed at enhancing the range and reliability of wireless wearable devices. Their innovations are designed to improve communication capabilities for a variety of applications, including Internet of Things (IoT), medical, and sports sectors. By increasing the transmission range and reducing signal dropouts, AntennaWare's solutions enable clients to achieve more effective connectivity in their wearable devices, ultimately supporting better performance and user experience.

VascVersa is a med-tech company focused on vascular regeneration through innovative regenerative medicine. It has developed a unique cell therapy that stimulates the formation of new blood vessels, enhancing blood supply and promoting long-term healing. This technology enables healthcare professionals to effectively treat patients with ischaemic diseases, addressing critical needs in vascular health. By prioritizing advancements in cell therapies, VascVersa aims to improve patient outcomes and support recovery in those affected by vascular-related conditions.

FjordStrong is a marine biodiversity technology company that specializes in underwater survey systems aimed at assessing conservation efforts for marine species. Its primary product, the Auto-release Baited Underwater Video system, facilitates the monitoring of high conservation value species and protected marine areas. In addition to the survey system, FjordStrong has developed customized software to efficiently process video data collected during biological surveys. This technology aids clients in streamlining data acquisition and analysis, ultimately supporting sustainable marine survey practices and enhancing the understanding of how marine renewable energy infrastructure impacts vulnerable wildlife.

Re-Vana Therapeutics Ltd is a company based in Belfast, United Kingdom, specializing in ocular pharmaceuticals and drug delivery systems. Founded in 2016, it focuses on developing biodegradable drug delivery platforms to treat chronic eye diseases, including age-related macular degeneration, diabetic retinopathy, glaucoma, and uveitis. The company offers two main products: OcuLief, which provides long-term release of therapeutics for age-related macular degeneration and diabetic retinopathy, and EyeLief, designed for glaucoma and retinal diseases. These platforms utilize FDA-approved polymers, enabling the delivery of various therapeutic molecules over periods ranging from one week to a year. Re-Vana's approach aims to enhance patient compliance through reduced treatment frequency and pain, while also minimizing side effects and healthcare costs.

Cibus Analytical operates as a food testing specialist. Cibus Analytical offer a laboratory testing service for food authenticity and safety, as well as extend its product offering to include portable testing tools to allow customers to rapidly test for food authenticity and safety at the point of sampling across global supply chains.

Sonrai Analytics develops an advanced analytics software platform aimed at enhancing data utilization for businesses in various sectors. Its platform leverages artificial intelligence and machine learning to enable predictive analytics, helping organizations discover new treatments and streamline research development. By addressing the challenges of precision analytics and reproducible data findings, Sonrai's solutions harness the vast amounts of data generated across successful business models. This approach allows companies to move away from outdated methods, facilitating the resolution of complex problems and the identification of competitive advantages in their respective markets.

Liopa Ltd, based in Belfast, United Kingdom, specializes in biometric authentication and verification technology. Founded in 2015, the company has developed LipVerify, a system that authenticates users by analyzing the appearance and movement of their lips as they speak into a camera. This technology leverages a Visual Speech Recognition platform called LipRead, which interprets lip movements, known as visemes, that correspond to spoken language. Notably, Liopa's solution operates without the need for additional hardware, functioning on any device equipped with a standard forward-facing camera, such as smartphones, tablets, and laptops. By integrating LipRead into existing voice recognition systems, Liopa aims to enhance the accuracy and user experience of voice-driven applications, effectively mitigating the challenges posed by background noise and promoting broader adoption of voice user interfaces.

Cirdan Imaging Limited specializes in the design, development, manufacturing, and supply of medical imaging products and software aimed at enhancing diagnostic processes. The company offers a range of solutions, including ULTRA, a laboratory information system that facilitates access to patient information across clinical laboratories, as well as PathLite and PathLite Compact, which cater to gross imaging applications. Additionally, Cirdan provides VividPath PACS, a software platform for image acquisition and annotation. Their solutions cover various medical fields, including clinical pathology and microbiology. Cirdan's products are distributed through a network across Europe, Australia, Canada, North America, and the Middle East. Founded in May 2010 and headquartered in Lisburn, Northern Ireland, Cirdan has expanded its presence with offices in Canada and Australia. The company was previously known as Beechmount Enterprises Limited before rebranding in June 2010.

Titan IC Systems (TICS) is a spin-out from the Institute of Electronics, Communications and Information Technology (ECIT) at Queen's University Belfast, a £40 million world-class centre with a unique focus on blue skies, strategic and industrial research projects.

ProAxsis Ltd. specialises in the development of laboratory-based immunoassays and rapid point-of-care tests for the capture, detection and measurement of active protease biomarkers of disease. Its rapid and easy-to-use tests incorporate patented “ProteaseTags®”; smart molecules which trap an active protease within a complex biological sample and enable a visual readout of its presence. A number of active protease species have been extensively validated as biomarkers of disease activity in areas such as cancer and infection, in addition to respiratory diseases such as bronchiectasis, cystic fibrosis and COPD. Its first immunoassay, for the specific measurement of active neutrophil elastase as a biomarker of lung infection and inflammation, was registered with a European CE Mark in 2016.

ActivWireless Ltd. specializes in providing wireless locating solutions across various industries, including healthcare, education, and industrial sectors. Founded in 2010 and based in Belfast, United Kingdom, the company offers a real-time locating system that includes the ActivServer appliance, networked RF readers, and ultra long-life tags. These tags come in various formats, such as key fobs, ID badge holders, and asset labels, allowing for the accurate and reliable identification of people and assets. The technology enables organizations to track both current and historical data on their assets and personnel, ensuring that information is accessible and dependable. ActivWireless emphasizes user-friendly software tailored to meet the specific needs of its clients while managing complex tracking requirements.

Nuada, based in Belfast, United Kingdom, specializes in the development and commercialization of advanced materials known as metal organic frameworks (MOFs). The company focuses on creating porous nano-materials that serve various applications, including the capture of carbon dioxide from power plant emissions, gas storage, and the separation and purification of chemicals. Additionally, Nuada's products contribute to medical applications and sensing technologies. Established in 2012, the company works collaboratively with partners to enhance the performance of its MOFs, tailoring their properties to meet specific application requirements while also producing low-cost, shaped MOFs suitable for real-world use.

Fusion Antibodies specializes in production of high quality humanized monoclonal antibodies and antibody engineering projects. The company has the knowledge and expertise to build and deliver a bespoke package of the services people need to achieve outstanding results. Using the technology, the sequences of the antibody variable domains which determine its binding specificity are incorporated into human donor sequences creating a panel of full length humanized antibodies for expression. Fully humanized monoclonal antibodies are an essential step in the progression of your drug to the clinic and the in-house expertise at Fusion Antibodies ensures its success. All of Fusion Antibodies services are offered on a fee-for-service basis and is flexible on the elements of the project people would like included. Fusion Antibodies have strong links with the several partners around the globe, allowing it to deliver a complete bespoke package, at an incredible price. Fusion Antibodies was founded on 2001 and is based in Belfast, United Kingdom.

Lagan Technologies Ltd. specializes in providing enterprise case management solutions tailored for government agencies, primarily in North America and Europe. The company offers a range of products, including an integrated case management system for governmental organizations, a performance solution for 311 call centers, and specialized systems for human services and motor vehicle management. Lagan Technologies also delivers a variety of services, such as project management, consultancy, installation, testing, integration, education and training, and ongoing support and maintenance. Founded in 1994 and headquartered in Belfast, the company has additional offices in London, Chicago, and Washington, D.C., serving advocates and councils both in the United Kingdom and internationally.

Axis Three is the market leader and pioneer of 3D surgical simulation tools for the cosmetic surgery market. Through its partnership with Siemens and its ground-breaking simulation software based on physics-driven tissue typing, Axis Three promises to create the new standard for 3D predictive surgical simulation.

Kainos Software Limited is a privately held software company headquartered in Belfast, Northern Ireland that develops information technology solutions for businesses and organisations particularly in the public, healthcare and financial services sectors. The company also provides consulting and support services. Kainos has offices in the UK, Ireland, Poland and the U.S., and provides services to its customers across Europe, the Middle East, Africa and North America. Kainos is one of Workday’s main implementation partners for the Workday SaaS product, and have developed Kainos Smart, an automated testing tool for Workday implementations. In the UK, Kainos provide an electronic medical record product for the digitisation of patient notes in the NHS called Evolve. The company also has a long-standing partnership with Autonomy delivering projects to organisations in Europe and Africa. Kainos has been a Microsoft Gold Certified Partner for more than 10 years, and was one of Microsoft's first Gold partners. Today, Kainos is one of Northern Ireland's largest high-tech companies, and one of the top companies in the UK and Ireland.